Insider Transactions in Q4 2025 at Inhibikase Therapeutics, Inc. (IKT)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2025
|
Sands Capital Life Sciences Pulse Fund Ii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,068,965
+13.71%
|
$2,068,965
$1.45 P/Share
|